Sahasra Pharmaceuticals India Private Limited
Founded in 1998 and headquartered in Tamil Nadu, India.
1998 | MadipakkamChennai-91., Tamil Nadu (India) | Active
Sahasra Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.26 K
- Company Age 26 Year, 11 Months
- Open Charges ₹ 1.25 M
About Sahasra Pharmaceuticals India
Sahasra Pharmaceuticals India Private Limited (SPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 March 1998 and has a history of 26 years and 11 months. Its registered office is in Madipakkam,Chennai-91., Tamil Nadu.
The Company is engaged in the Chemicals Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.26 K .
The company currently has active open charges totaling ₹1.25 M.
Sivakaminatha Samia and Sivakaminatha Senthilnathan serve as directors at the Company.
Company Details
- Location Madipakkam,Chennai-91., Tamil Nadu
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231TN1998PTC040209
- Company No.
040209
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Mar 1998
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Chemicals
Pharmaceuticals
Who are the key members and board of directors at Sahasra Pharmaceuticals India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sivakaminatha Samia  | Director | 27-Mar-1998 | Current |
| Sivakaminatha Senthilnathan | Director | 27-Mar-1998 | Current |
Financial Performance of Sahasra Pharmaceuticals India.
Enhance accessibility to Sahasra Pharmaceuticals India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sahasra Pharmaceuticals India?
Unlock access to Sahasra Pharmaceuticals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹1.25 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Aug 1998 | Canara Bank | ₹1.25 M | Open |
How Many Employees Work at Sahasra Pharmaceuticals India?
Unlock and access historical data on people associated with Sahasra Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sahasra Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sahasra Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.